Ifeanyi Beverly Chukwudozie

Mrs. Ifeanyi Beverly Chukwudozie

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2018 in Cancer
Verified
Journal Article
Closed access
PDF file
KHKent F. Hoskins
Kent F. Hoskins
STSilvia Tejeda
Silvia Tejeda
GVGanga Vijayasiri
Ganga Vijayasiri
ICIfeanyi Beverly Chukwudozie
Ifeanyi Beverly Chukwudozie
MRMylene H. Remo
Mylene H. Remo
RWRichard B. Warnecke
Richard B. Warnecke

1 January 2017 in Contemporary Clinical Trials
Verified
Journal Article
Closed access
DHDenise M. Hynes
Denise M. Hynes
MFMichael J. Fischer
Michael J. Fischer
LSLinda A. Schiffer
Linda A. Schiffer
RGRani Gallardo
Rani Gallardo
ICIfeanyi Beverly Chukwudozie
Ifeanyi Beverly Chukwudozie
MFMarian L. Fitzgibbon
Marian L. Fitzgibbon

25 June 2022 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
VHVida A. Henderson
Vida A. Henderson
JMJessica Madrigal
Jessica Madrigal
LKLe’ Chaun Kendall
Le’ Chaun Kendall
PPPooja Parekh
Pooja Parekh
JNJennifer Newsome
Jennifer Newsome
KHKent F. Hoskins
Kent F. Hoskins
Background: Despite the benefits of genetic counseling and testing, uptake of cancer genetic services is generally low and Black/African American (Black) women are substantially less likely to receive genetic services than non-Hispanic White women. Our team developed a culturally sensitive, narrative decision aid video to promote uptake of genetic counseling among Black women at risk for a hereditary breast cancer syndrome that can be incorporated in conjunction with population-based cancer risk assessment in a clinical setting. We report here a pilot study to demonstrate changes in intention to access genetic counseling and intervention satisfaction. Methods: Black women who were personally unaffected by breast cancer and were recommended for genetic counseling based on family history screening in a mammography center were recruited at the time of the mammogram. A prospective, pre-post survey study design, guided by theoretical constructs, was used to evaluate baseline and immediate post-intervention psychosocial factors, including intention to participate in genetic counseling and intervention satisfaction. Results: Pilot recruitment goals were met (n = 30). Pre-intervention, 50% of participants indicated that they were extremely likely to make a genetic counseling appointment, compared with 70% post-intervention (p = 0.05). After watching the intervention, 50% of participants indicated that the video changed their mind regarding genetic counseling. Conclusions: This study demonstrated cultural satisfaction with a decision aid intervention designed to motivate Black women with hereditary breast cancer risk to attend a genetic counseling appointment. Our study showed that intention may be a specific and key construct to target in interventions designed to support decision-making about genetic services. Study results informed the design of a subsequent large scale, randomized implementation study. Trial registration: Trial registration: Clinicaltrials.gov NCT04082117. Registered September 9, 2019. Retrospectively registered.

23 May 2018 in Translational Behavioral Medicine
Verified
Journal Article
Open access
PDF file
ICIfeanyi Beverly Chukwudozie
Ifeanyi Beverly Chukwudozie
MFMarian L Fitzgibbon
Marian L Fitzgibbon
LSLinda Schiffer
Linda Schiffer
MBMichael Berbaum
Michael Berbaum
CGCheryl Gilmartin
Cheryl Gilmartin
DHDenise M Hynes
Denise M Hynes
Patients with chronic kidney disease have a high disease burden may benefit from primary care services and care coordination. A medical home model with direct access to primary care services is one approach that may address this need, yet has not been examined. As a substudy of the Patient-Centered Outcomes Research Institute (PCORI) patient-centered medical home for kidney disease (PCMH-KD) health system intervention study, we examined the uptake of free primary care physician (PCP) services. The PCORI PCMH-KD study was an initial step toward integrating PCPs, a nurse coordinator, a pharmacist, and community health workers (CHWs) within the health care delivery team. Adult chronic hemodialysis (CHD) at two urban dialysis centers were enrolled in the intervention. We examined trends and factors associated with the use of the PCMH-KD PCP among two groups of patients based on their report of having a regular physician for at least six months (established-PCP) or not (no-PCP). Of the 173 enrolled patients, 91 (53%) patients had at least one visit with the PCMH-KD PCP. The rate of visits was higher in those in the no-PCP group compared with those in the established-PCP group (62% vs. 41%, respectively). Having more visits with the CHW was positively associated with having a visit with the PCMH-KD PCPs for both groups. Embedded CHWs within the care team played a role in facilitating the uptake of PCMH-KD PCP. Lessons from this health system intervention can inform future approaches on the integration of PCPs and care coordination for CHD patients.

1 June 2013 in Environmental Justice
Verified
Journal Article
Closed access
KOKristin M. Osiecki
Kristin M. Osiecki
SKSeijeoung Kim
Seijeoung Kim
ICIfeanyi Beverly Chukwudozie
Ifeanyi Beverly Chukwudozie
ECElizabeth A. Calhoun
Elizabeth A. Calhoun
Health disparities research has focused primarily on racial and socioeconomic differences in health outcomes. Although neighborhood characteristics and the concept of built environment have been shown to affect individual health, measuring the effects of environmental risks on health has been a less developed area of disparities research. To examine spatial associations and the distribution of geographic patterns of sociodemographic characteristics, environmental cancer risk, and cancer rates, we utilized existing data from multiple sources. The findings from our initial analysis, which concerned with proximity to environmental hazards and at-risk communities, were consistent with results of previous studies, which often reported mixed relationships between health disparity indicators and environmental burden. However, further analysis with refined models showed that several key demographic and subdomains of cancer risk measures were shown to have spatial components. With the application of exploratory spatial data analysis, we were able to identify areas with both high rates of poverty and racial minorities to further examine for possible associations to environmental cancer risk. Global spatial autocorrelation found spatial clustering with percent black, percent poverty, point and non-point cancer risks requiring further spatial analysis to determine relationship of significance based on geography. This methodology was based upon particular assumptions associated with data and applications, which needed to be met. We conclude that careful assessment of the data and applications were required to properly interpret the findings in understanding the relationship between vulnerable populations and environmental burden.

11 November 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ALAndrea Lamont
Andrea Lamont
LHLewis L. Hsu
Lewis L. Hsu
SJSara Jacobs
Sara Jacobs
RGRobert Gibson
Robert Gibson
MTMarsha Treadwell
Marsha Treadwell
TCthe Sickle Cell Disease Implementation Consortium
the Sickle Cell Disease Implementation Consortium
Accruing evidence reveals best practices for how to help individuals living with Sickle Cell Disease (SCD); yet, the implementation of these evidence-based practices in healthcare settings is lacking. The Sickle Cell Disease Implementation Consortium (SCDIC) is a national consortium that uses implementation science to identify and address barriers to care in SCD. The SCDIC seeks to understand how and why patients become unaffiliated from care and determine strategies to identify and connect patients to care. A challenge, however, is the lack of agreed-upon definition for what it means to be unaffiliated and what it means to be a “SCD expert provider”. In this study, we conducted a Delphi process to obtain expert consensus on what it means to be an “unaffiliated patient” with SCD and to define an “SCD specialist,” as no standard definition is available. Twenty-eight SCD experts participated in three rounds of questions. Consensus was defined as 80% or more of respondents agreeing. Experts reached consensus that an individual with SCD who is unaffiliated from care is “someone who has not been seen by a sickle cell specialist in at least a year.” A sickle cell specialist was defined as someone with knowledge and experience in SCD. Having “knowledge” means: being knowledgeable of the 2014 NIH Guidelines, “Evidence-Based Management of SCD”, trained in hydroxyurea management and transfusions, trained on screening for organ damage in SCD, trained in pain management and on SCD emergencies, and is aware of psychosocial and cognitive issues in SCD. Experiences that are expected of a SCD specialist include experience working with SCD patients, mentored by a SCD specialist, regular attendance at SCD conferences, and obtains continuing medical education on SCD every 2 years.” The results have strong implications for future research, practice, and policy related to SCD by helping to lay a foundation for an new area of research (e.g., to identify subpopulations of unaffiliation and targeted interventions) and policies that support reaffiliation and increase accessibility to quality care.